ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED

Transcripts Elixiron Immunotherapeutics (Cayman) Limited

Stocks

7871

KYG3106D1016

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 2026-10-05			5-day change	1st Jan Change
149.00 ^TWD	-3.25%		-8.02%	-

08-13	Elixiron Immunotherapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-10	Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results For Enrupatinib In Alzheimer's Disease	CI

Transcripts

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
7871 Stock
News Elixiron Immunotherapeutics (Cayman) Limited
Transcripts

As early as today, start finding the best investment opportunities!